Exosomes Market

Global Exosomes Market by Types (Non-coding RNAs, mRNA, Proteins, DNA Fragments, and Lipids), Products (Kits &Reagents, Instruments, and Others), Isolation Methods (Ultracentrifugation, Immunocapture on Beads, Precipitation, and Filtration), Applications (Diagnostics and Therapeutics), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

  • Report ID: HC-902
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 134
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global exosomes market is estimated to expand at a substantial CAGR during the forecast period, 2021-2028. Exosomes are membrane-bound vesicles produced by most eukaryotic cells. They appear in several body fluids that comprise RNA and proteins. These body fluids assist in intercellular communication and can transfer molecules between cells. They possess ability to circulate proteins and are used for therapeutic purposes such as drug delivery systems and biomarkers besides the treatment of cancer and cardiovascular diseases. Nanovesicles play a key role in intercellular communication and are projected to observe a size able rise in R&D, which is expected to boost revenue growth of the market in the coming years.

Market Trends, Drivers, Restraints, and Opportunities:

  • Rising pervasiveness of cancer, technological improvements in exosome isolation, and analytical procedures are key driving factors of the market.
  • Exosomes extricated from cow milk are utilized for the delivery of therapeutic molecules to fight breast and lung cancer. The anti-cancer vaccines possess the ability to cross the biological barriers. Hence, the rise in the number of cancer cases directly upsurges the demand for exosomes used for therapeutics and diagnosis.
  • Technical complications in the employment of exosomes is a major hindrance to the development of the exosomes market.
  • Challenges such as rising the homogeneity of exosomes, streamlining of purification, and efficient transfection strategies are expected to create major hurdles of the market.
  • The cumbrous isolation techniques and the incapability to determine cancer stages along with inadequate comprehension of the immune system are some key challenges for the market.
  • Strict regulatory regarding the approval of exosomes related products is another key retraining factor that can impede the market growth during the forecast period.

Scope of the report:

The report on the global exosomes market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast.

Global Exosomes Market Segment Insights:

Global Exosomes Market Taxonomy

Therapeutic segment to show immense growth
On the basis of applications, the global exosomes market can be segmented into diagnostics and therapeutics. The therapeutic segment is anticipated to grow significantly as exosomes possess the competence to act as excellent therapeutic platform for multiple ailments including SARS-CoV-2. Exosomes can be used in clinical applications for tissue regeneration and can by-pass cellular toxicity and immune rejection while delivering therapeutic cargo components. Exosomes possess properties to be a great drug delivery vehicle and high biocompatibility to deliver proteins, chemicals, and nucleic acids.

mRNA to hold a significant market share
Based on types, the global exosomes market can be divided into non-coding RNAs, mRNA, proteins, DNA fragments, and lipids. The mRNA segment is anticipated to hold a considerable share of the market during the forecast period as it acts as intercellular communication mediators, transporting the mRNA transcripts to cells all over the body. Exosomes derived from dendritic and mesenchymal stem cells with therapeutic potential are efficient agents against diseases; thus, impacting positively on the mRNA segment.

North America constitutes a large share of the global market
In terms of regions, the global exosomes market can be classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds a significant share in the exosomes market, which can be attributed to enhanced healthcare infrastructure, efficient government rules, and wide awareness among public about healthcare and diagnostics. The market in Asia pacific is anticipated to grow in terms of revenue during the forecast period owing to gradual progress in acquiring infrastructure for exosomes development.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Exosomes Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Exosomes Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Exosomes Market - Supply Chain
  4.5. Global Exosomes Market Forecast
     4.5.1. Exosomes Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Exosomes Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Exosomes Market Absolute $ Opportunity
5. Global Exosomes Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Exosomes Market Size and Volume Forecast by Types
     5.3.1. Non-coding RNAs
     5.3.2. mRNA
     5.3.3. Proteins
     5.3.4. DNA Fragments
     5.3.5. Lipids
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Exosomes Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Exosomes Market Size and Volume Forecast by Applications
     6.3.1. Diagnostics
     6.3.2. Therapeutics
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Exosomes Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Exosomes Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Exosomes Demand Share Forecast, 2019-2026
8. North America Exosomes Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Exosomes Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Exosomes Market Size and Volume Forecast by Types
     8.4.1. Non-coding RNAs
     8.4.2. mRNA
     8.4.3. Proteins
     8.4.4. DNA Fragments
     8.4.5. Lipids
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Exosomes Market Size and Volume Forecast by Applications
     8.7.1. Diagnostics
     8.7.2. Therapeutics
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Exosomes Demand Share Forecast, 2019-2026
9. Latin America Exosomes Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Exosomes Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Exosomes Market Size and Volume Forecast by Types
     9.4.1. Non-coding RNAs
     9.4.2. mRNA
     9.4.3. Proteins
     9.4.4. DNA Fragments
     9.4.5. Lipids
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Exosomes Market Size and Volume Forecast by Applications
     9.7.1. Diagnostics
     9.7.2. Therapeutics
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Exosomes Demand Share Forecast, 2019-2026
10. Europe Exosomes Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Exosomes Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Exosomes Market Size and Volume Forecast by Types
     10.4.1. Non-coding RNAs
     10.4.2. mRNA
     10.4.3. Proteins
     10.4.4. DNA Fragments
     10.4.5. Lipids
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Exosomes Market Size and Volume Forecast by Applications
     10.7.1. Diagnostics
     10.7.2. Therapeutics
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Exosomes Demand Share Forecast, 2019-2026
11. Asia Pacific Exosomes Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Exosomes Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Exosomes Market Size and Volume Forecast by Types
     11.4.1. Non-coding RNAs
     11.4.2. mRNA
     11.4.3. Proteins
     11.4.4. DNA Fragments
     11.4.5. Lipids
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Exosomes Market Size and Volume Forecast by Applications
     11.7.1. Diagnostics
     11.7.2. Therapeutics
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Exosomes Demand Share Forecast, 2019-2026
12. Middle East & Africa Exosomes Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Exosomes Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Exosomes Market Size and Volume Forecast by Types
     12.4.1. Non-coding RNAs
     12.4.2. mRNA
     12.4.3. Proteins
     12.4.4. DNA Fragments
     12.4.5. Lipids
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Exosomes Market Size and Volume Forecast by Applications
     12.7.1. Diagnostics
     12.7.2. Therapeutics
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Exosomes Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Exosomes Market: Market Share Analysis
  13.2. Exosomes Distributors and Customers
  13.3. Exosomes Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Codiak BioSciences
     13.4.2. Evox Therapeutics Limited
     13.4.3. HansaBioMed Life Sciences
     13.4.4. Illumina Inc.
     13.4.5. Lonza
     13.4.6. Miltenyi Biotec
     13.4.7. Norgen Biotek Corp
     13.4.8. System Biosciences LLC&l
Segments Covered in the Report
The global exosomes market can be divided based on types, products, isolation methods, applications, and regions.

Types
  • Non-coding RNAs
  • mRNA
  • Proteins
  • DNA Fragments
  • Lipids
Products
  • Kits &Reagents
  • Instruments
  • Others
Isolation Methods
  • Ultracentrifugation
  • Immunocapture on Beads
  • Precipitation
  • Filtration
Applications
  • Diagnostics
  • Therapeutics
Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa
Key Players
  • Codiak BioSciences
  • Evox Therapeutics Limited
  • HansaBioMed Life Sciences
  • Illumina Inc.
  • Lonza
  • Miltenyi Biotec
  • Norgen Biotek Corp
  • System Biosciences LLC
  • Takara Bio Company
  • Thermo Fisher Scientific Inc.

The global exosomes market is extremely competitive due to the huge number of competitors. Major players in the global exosomes market include Codiak BioSciences, Evox Therapeutics Limited, HansaBioMed Life Sciences, Illumina Inc., Lonza, Miltenyi Biotec, Norgen Biotek Corp, System Biosciences, LLC, Takara Bio Company, and Thermo Fisher Scientific, Inc. Many companies have adopted R&D as a business strategy tool to withstand the competition. Some of them are actively involved in other market activities such as expansions, joint ventures, acquisitions, and others to increase their market share. The strategies are aimed at providing better quality and new features to customers.

Buy Report